Company: BIVIW
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001520138-25-000343
Chunk: 4

Company: BIOVIE INC.
Filing Date: 2025-11-10
Form: 10-Q
Item: Part I, Item 1
Chunk 4
---
-  
     -  
     -  
     270,559 

    Proceeds from issuance of common stock, net of costs of  $1,543,038 
     5,620,000  
     562  
     10,457,067  
     -  
     -  
     -  
     -  
     10,457,629 

    Issuance of common stock from vesting of restricted stock units 
     3,255  
     -  
     -  
     -  
     -  
     -  
     -  
     - 

    Deemed dividend for ratchet adjustment to warrants 
     -  
     -  
     43,544  
     -  
     -  
     -  
     (43,544) 
     - 

    Net Loss 
     -  
     -  
     -  
     -  
     -  
     -  
     (5,087,557) 
     (5,087,557)

    Balance, September 30, 2025 
     7,540,316  
    $754  
    $382,195,626  
     (2,837) 
    $(29) 
    $-  
    $(357,275,347) 
    $24,921,004 

See accompanying notes to unaudited condensed financial
statements

6

BioVie Inc.

Condensed Statements of Cash Flows

(Unaudited) 

    Three Months Ended  
    Three Months Ended 

    September 30, 2025  
    September 30, 2024 

    CASH FLOWS FROM OPERATING ACTIVITIES: 

    Net loss 
    $(5,087,557) 
    $(4,152,032)
  
    Adjustments to reconcile net loss to net cash used in operating activities: 

    Amortization of intangible assets 
     57,344  
     57,344 
  
    Stock based compensation - restricted stock units and restricted shares 
     270,559  
     301,491 
  
    Stock based compensation expense - stock options 
     268,388